AI

Alphabet Inc Portfolio holdings

AUM $2.14B
This Quarter Return
+51.28%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$2.14B
AUM Growth
+$2.14B
Cap. Flow
-$84.6M
Cap. Flow %
-3.96%
Top 10 Hldgs %
89.61%
Holding
40
New
Increased
Reduced
2
Closed
4

Top Buys

No buys this quarter

Sector Composition

1 Technology 55.72%
2 Healthcare 35.16%
3 Industrials 9.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ASTS icon
1
AST SpaceMobile
ASTS
$13.2B
$418M 19.57% 8,943,486
ARM icon
2
Arm
ARM
$147B
$317M 14.85% 1,960,784
FRSH icon
3
Freshworks
FRSH
$3.93B
$242M 11.32% 16,206,643
PL icon
4
Planet Labs
PL
$2.15B
$195M 9.13% 31,942,641
RVMD icon
5
Revolution Medicines
RVMD
$7.1B
$152M 7.12% 4,133,277
MTSR
6
Metsera, Inc. Common Stock
MTSR
$3.71B
$141M 6.61% 4,961,744
VERV
7
DELISTED
Verve Therapeutics
VERV
$137M 6.4% 12,168,489 -180,597 -1% -$2.03M
GTLB icon
8
GitLab
GTLB
$7.93B
$123M 5.76% 2,724,712
TEM
9
Tempus AI, Inc. Class A Common Stock
TEM
$13.2B
$98.6M 4.62% 1,551,102
DXCM icon
10
DexCom
DXCM
$29.5B
$90.5M 4.24% 1,036,937
PATH icon
11
UiPath
PATH
$5.95B
$90M 4.22% 7,034,337
PRME icon
12
Prime Medicine
PRME
$578M
$37.2M 1.74% 15,062,498
MAZE
13
Maze Therapeutics, Inc. Common Stock
MAZE
$635M
$29.6M 1.39% 2,412,471
OSCR icon
14
Oscar Health
OSCR
$4.31B
$10.3M 0.48% 481,988
SANA icon
15
Sana Biotechnology
SANA
$777M
$7.68M 0.36% 2,812,500
GLUE icon
16
Monte Rosa Therapeutics
GLUE
$296M
$6.6M 0.31% 1,464,015
VERA icon
17
Vera Therapeutics
VERA
$1.38B
$5.68M 0.27% 241,264
BEAM icon
18
Beam Therapeutics
BEAM
$1.66B
$5.47M 0.26% 321,604
RLAY icon
19
Relay Therapeutics
RLAY
$619M
$5.43M 0.25% 1,568,753
DNTH icon
20
Dianthus Therapeutics
DNTH
$759M
$3.89M 0.18% 208,697
LYEL icon
21
Lyell Immunopharma
LYEL
$213M
$2.59M 0.12% 293,256 -5,571,869 -95% -$49.3M
SPRO icon
22
Spero Therapeutics
SPRO
$116M
$2.58M 0.12% 889,979
FHTX icon
23
Foghorn Therapeutics
FHTX
$286M
$2.35M 0.11% 500,901
WGS icon
24
GeneDx Holdings
WGS
$3.72B
$2.1M 0.1% 22,711
AUTL
25
Autolus Therapeutics
AUTL
$399M
$1.59M 0.07% 698,262